While it's certainly a red flag that 3,009 options contracts were traded on aQuantive Inc. (NASDAQ: AQNT) yesterday (32 times the trailing daily average), it's also the case that the smart money was already on aQuantive. After DoubleClick was purchased by Google for a whopping $3.1 billion, our writers were quick to point out that aQuantive was a good bet to follow -- Georges Yared posted about aQuantive's attractiveness on April 16, and Brent Archer followed up the same day surmising that Microsoft Corp. (NASDAQ: MSFT) might overbid on the advertising company.
If you bought aQuantive after being told that it (along with Apple Inc (NASDAQ: AAPL) was one of the two stocks to buy for Dow 14,000? You'd be up 77% today along with the rest of the lucky aQuantive shareholders. You got another chance when Larry Schutts pegged aQuantive as one of the "industry's best known practitioners" a few days ago (he recommended it much earlier in February). Back in February, Georges Yared also wrote three posts recommending the stock, before the company reported quarterly financial results, after it reported a great quarter, and also after ValueClick Inc (NASDAQ: VCLK) reported, claiming both are stocks to own.
Surely, a lot of pundits were picking aQuantive as a potential good buy once DoubleClick was sold, but it's worthwhile to note it's not the only time our writers have been right. Want a couple of other companies our bloggers have been hot for lately? Try ValueClick Inc (NASDAQ: VCLK) -- blog, or Crocs Inc. (NASDAQ: CROX) -- blog, two stocks that have all the BloggingStocks folks up late at night dreaming of big, big things.
Last updated: February 13, 2012: 01:34 AM
Hot Stocks
DailyFinance Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
Benzinga Headlines
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
TheFlyOnTheWall.com Headlines
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger


Reader Comments (Page 1 of 1)
5-18-2007 @ 3:21PM
Robert Freedland said...
I don't mean to gloat or anything, but I had the good fortune of picking (unfortunately not for my own portfolio) aQuantive (AQNT) on October 14, 2003, when the stock was trading at $13.34/share. (http://bobsadviceforstocks.tripod.com/bobsadviceforstocks/index.blog?entry_id=107949)
But I pick lots of stocks for my blog, so I don't want to claim brilliance, but hey, it WAS a good pick wasn't it?
Bob
"Stock Picks Bob's Advice" http://bobsadviceforstocks.tripod.com/bobsadviceforstocks/